Resolution Minerals (ASX:RML) has secured firm commitments for approximately A$20 million in a two-tranche institutional placement priced at A$0.07 per share, representing a 6.3% premium to the 20-day volume weighted average price. The raising was cornerstoned by Tribeca Investment Partners and L1 Capital Global Opportunities Master Fund.
The pricing is notable. Placements at a premium to VWAP are uncommon for pre-revenue ASX explorers, and the calibre of cornerstone investors suggests strong institutional conviction ahead of the company's upcoming Nasdaq listing.
Placement structure
The placement will see approximately 285.7 million new shares issued across two tranches:
- Tranche 1 — A$9.21 million via the issue of 131.6 million shares, settling on or around 29 April 2026 under the company's existing placement capacity.
- Tranche 2 — A$10.78 million via the issue of 154.1 million shares, subject to shareholder approval and expected to settle within approximately 60 days.
Use of proceeds
Funds will be deployed to accelerate activity across the Horse Heaven Project in Idaho, specifically:
- Further exploration drilling
- Metallurgical test work for tungsten and antimony
- Permitting activities
- The Phase 2 drilling campaign at Golden Gate, comprising up to 13,700 metres of diamond drilling commencing May 2026, targeting a maiden Mineral Resource Estimate in Q1 2027
The company has also reported the production of high-purity antimony trioxide (99.38 wt%) and the acquisition of the Johnson Creek Tungsten and Antimony Mill, indicating an integrated development pathway spanning exploration, metallurgy and downstream processing.
Nasdaq listing
The placement leaves RML well-funded ahead of its planned Nasdaq listing in the coming weeks. A US listing is expected to broaden access to North American institutional capital, improve liquidity and position RML alongside other critical minerals peers listed on US exchanges — a cohort that has historically traded at valuation multiples materially above ASX comparables.
Strategic backdrop
The raising takes place against a constructive macro backdrop for US-focused antimony and tungsten developers. Antimony Ridge, which forms part of the broader Horse Heaven Project, has been formally included in the US Federal FAST-41 Permitting Transparency Program — one of only three ASX-listed projects to receive the designation.
FAST-41 inclusion is expected to provide enhanced inter-agency coordination, transparent milestone tracking and accelerated permitting timelines. The designation follows the Trump Administration's Executive Order on Immediate Measures to Increase American Mineral Production, reflecting federal policy aimed at reducing reliance on foreign supply chains for critical minerals.
Antimony Ridge has historical relevance as a past supplier of antimony to the US government during World War I, World War II and the Korean War. The project is located adjacent to Perpetua Resources' Stibnite Gold Project, reinforcing the region's emergence as a strategic hub for US domestic critical minerals development.
Near-term catalysts
RML now presents a stacked catalyst pipeline:
- Settlement of Tranche 1 (late April 2026)
- Planned Nasdaq listing (coming weeks)
- Commencement of Phase 2 drilling at Golden Gate (May 2026)
- Shareholder meeting and Tranche 2 settlement (~60 days)
- Advancement of the Antimony Ridge Plan of Operations under FAST-41
- Maiden Mineral Resource Estimate targeted for Q1 2027
Cashu Research view
The combination of a premium-priced, institutionally anchored raising, an imminent Nasdaq listing and federal-level permitting support positions RML as one of the more strategically significant critical minerals stories on the ASX. Execution risk remains — exploration outcomes, permitting timelines and US listing reception are all material variables — however, the convergence of capital, policy and project catalysts over the next twelve months warrants close attention from investors focused on the US critical minerals theme.
This article is intended as general commentary and does not constitute financial advice. Investors should conduct their own research and consult a licensed adviser before making investment decisions.